Loading the company…
Loading the company…
In the last ten years FDA made 75 decisions for Medinol (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2018 (16). The latest was on 2026-08-06.
| Family | Decisions on record |
|---|---|
| Coronary intervention (PCI) | 98 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-08-06 | PMA | P170008-S064 | EluNIR Ridaforolimus Eluting Coronary Stent System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-03-26 | PMA | P170008-S062 | EluNIR Ridaforolimus Eluting Coronary Stent System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-02-04 | PMA | P170008-S061 | EluNIR Ridaforolimus Eluting Coronary Stent System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2025-10-02 | PMA | P170008-S056 |
| EluNIR Ridaforolimus Eluting Coronary Stent System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2025-08-15 | PMA | P170008-S060 | EluNIR Ridaforolimus Eluting Coronary Stent System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Medinol.